149 related articles for article (PubMed ID: 36180343)
1. Development of a combination antibiogram for empirical treatments of Pseudomonas aeruginosa at a university-affiliated teaching hospital.
Ai MY; Lu HE; Lee WY; Liu HY; Chuang HC; Chen BL; Wang EY; Tsao LH; Lee YJ
J Microbiol Immunol Infect; 2023 Apr; 56(2):344-350. PubMed ID: 36180343
[TBL] [Abstract][Full Text] [Related]
2. A Combination Antibiogram Evaluation for
Puzniak L; DePestel DD; Srinivasan A; Ye G; Murray J; Merchant S; DeRyke CA; Gupta V
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917987
[No Abstract] [Full Text] [Related]
3. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.
Shahri FN; Izanloo A; Goharrizi MASB; Jamali A; Bagheri H; Hjimohammadi A; Ardebili A
Int Microbiol; 2022 Nov; 25(4):709-721. PubMed ID: 35697891
[TBL] [Abstract][Full Text] [Related]
5. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.
Karlowsky JA; Draghi DC; Jones ME; Thornsberry C; Friedland IR; Sahm DF
Antimicrob Agents Chemother; 2003 May; 47(5):1681-8. PubMed ID: 12709340
[TBL] [Abstract][Full Text] [Related]
6.
Goodlet KJ; Nicolau DP; Nailor MD
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
[TBL] [Abstract][Full Text] [Related]
7. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
Hsueh PR; Chen WH; Luh KT
Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
[TBL] [Abstract][Full Text] [Related]
8. Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model.
Avent ML; McCarthy KL; Sime FB; Naicker S; Heffernan AJ; Wallis SC; Paterson DL; Roberts JA
Microbiol Spectr; 2022 Jun; 10(3):e0052522. PubMed ID: 35442072
[TBL] [Abstract][Full Text] [Related]
9. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
Henderson A; Tan E; McCarthy KL; Paterson DL
Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
[TBL] [Abstract][Full Text] [Related]
10. Ability of an antibiogram to predict Pseudomonas aeruginosa susceptibility to targeted antimicrobials based on hospital day of isolation.
Anderson DJ; Miller B; Marfatia R; Drew R
Infect Control Hosp Epidemiol; 2012 Jun; 33(6):589-93. PubMed ID: 22561714
[TBL] [Abstract][Full Text] [Related]
11. Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.
Burgess DS; Nathisuwan S
Diagn Microbiol Infect Dis; 2002 Sep; 44(1):35-41. PubMed ID: 12376029
[TBL] [Abstract][Full Text] [Related]
12. Correlation between antibiotic consumption and resistance of Pseudomonas aeruginosa in a teaching hospital implementing an antimicrobial stewardship program: A longitudinal observational study.
Huang HW; Liu HY; Chuang HC; Chen BL; Wang EY; Tsao LH; Ai MY; Lee YJ
J Microbiol Immunol Infect; 2023 Apr; 56(2):337-343. PubMed ID: 36210318
[TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates.
Khan M; Ma K; Wan I; Willcox MD
Cont Lens Anterior Eye; 2023 Jun; 46(3):101819. PubMed ID: 36732125
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the In Vitro Susceptibility of Ceftolozane-Tazobactam With the Cumulative Susceptibility Rates of Standard Antibiotic Combinations When Tested Against
Shortridge D; Pfaller MA; Arends SJR; Raddatz J; DePestel DD; Flamm RK
Open Forum Infect Dis; 2019 Jun; 6(6):ofz240. PubMed ID: 31263733
[TBL] [Abstract][Full Text] [Related]
15. Activity of ceftolozane/tazobactam against Gram-negative isolates among different infections in Hong Kong: SMART 2017-2019.
Karlowsky JA; Lob SH; Khan A; Chen WT; Woo PCY; Seto WH; Ip M; Leung S; Wong QW; Chau RWY; DeRyke CA; Young K; Motyl MR; Sahm DF
J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35451945
[No Abstract] [Full Text] [Related]
16. Pseudomonas aeruginosa susceptibility, antibiogram and clinical interpretation, and antimicrobial prescribing behaviors for dogs with otitis in the Midwestern United States.
KuKanich KS; Bagladi-Swanson M; KuKanich B
J Vet Pharmacol Ther; 2022 Sep; 45(5):440-449. PubMed ID: 35698441
[TBL] [Abstract][Full Text] [Related]
17. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
[TBL] [Abstract][Full Text] [Related]
18. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections.
Van Eldere J
J Antimicrob Chemother; 2003 Feb; 51(2):347-52. PubMed ID: 12562701
[TBL] [Abstract][Full Text] [Related]
19. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
Er H; Altındiş M; Aşık G; Demir C
Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
[TBL] [Abstract][Full Text] [Related]
20. Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
Mumtaz K; Munir S; Muddassir M; Raza A; Waqas K; Shoaib Ahmed S; Malik A; Haider Naqvi SZ
Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1111-1118. PubMed ID: 34602440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
